"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
| Descriptor ID |
D000998
|
| MeSH Number(s) |
D27.505.954.122.388
|
| Concept/Terms |
Antiviral Agents- Antiviral Agents
- Agents, Antiviral
- Antivirals
- Antiviral Drugs
- Drugs, Antiviral
|
Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".
This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 9 | 2 | 11 |
| 1996 | 10 | 3 | 13 |
| 1997 | 8 | 4 | 12 |
| 1998 | 9 | 2 | 11 |
| 1999 | 9 | 3 | 12 |
| 2000 | 2 | 3 | 5 |
| 2001 | 7 | 5 | 12 |
| 2002 | 5 | 6 | 11 |
| 2003 | 6 | 5 | 11 |
| 2004 | 8 | 3 | 11 |
| 2005 | 6 | 3 | 9 |
| 2006 | 14 | 5 | 19 |
| 2007 | 13 | 7 | 20 |
| 2008 | 5 | 5 | 10 |
| 2009 | 6 | 6 | 12 |
| 2010 | 9 | 3 | 12 |
| 2011 | 17 | 4 | 21 |
| 2012 | 8 | 2 | 10 |
| 2013 | 7 | 4 | 11 |
| 2014 | 19 | 1 | 20 |
| 2015 | 14 | 4 | 18 |
| 2016 | 10 | 1 | 11 |
| 2017 | 7 | 5 | 12 |
| 2018 | 4 | 3 | 7 |
| 2019 | 9 | 7 | 16 |
| 2020 | 8 | 10 | 18 |
| 2021 | 12 | 11 | 23 |
| 2022 | 1 | 4 | 5 |
| 2023 | 1 | 6 | 7 |
| 2024 | 9 | 7 | 16 |
| 2025 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antiviral Agents" by people in Profiles.
-
Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international study. Surgery. 2025 Jul; 183:109396.
-
Functional Cure for Hepatitis B Virus: Challenges and Achievements. Int J Mol Sci. 2025 Apr 11; 26(8).
-
Chemical-guided SHAPE sequencing (cgSHAPE-seq) informs the binding site of RNA-degrading chimeras targeting SARS-CoV-2 5' untranslated region. Nat Commun. 2025 Jan 08; 16(1):483.
-
Neonatal Cytomegalovirus Infection: Advocacy, Legislation, and Changing Practice. Clin Perinatol. 2025 Mar; 52(1):115-132.
-
Impact of Letermovir for Cytomegalovirus Primary Prophylaxis on Myelosuppression and Immunosuppression in Lung Transplant Recipients. Clin Transplant. 2024 Dec; 38(12):e70033.
-
Design and Pilot Implementation of an ECHO Module on Hepatitis C Virus Infection During Pregnancy. J Pediatric Infect Dis Soc. 2024 Nov 21; 13(Supplement_5):S179-S182.
-
Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review. JAMA. 2024 11 19; 332(19):1652-1662.
-
Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma. JAMA. 2024 09 24; 332(12):1013-1014.
-
A drug repurposing screen identifies decitabine as an HSV-1 antiviral. Microbiol Spectr. 2024 Nov 05; 12(11):e0175424.
-
A randomized, placebo-controlled, dose-escalation phase I/II multicenter trial of low-dose cidofovir for BK polyomavirus nephropathy. Transpl Infect Dis. 2024 Dec; 26(6):e14367.